Oxford Nanopore Technologies (ONT) long-read sequencing (LRS) has emerged as a promising genomic analysis tool, yet comprehensive benchmarks with established platforms across diverse datasets remain limited. This study aimed to benchmark LRS performance against Illumina short-read sequencing (SRS) and microarrays for variant detection across different genomic contexts and to evaluate the impact of experimental factors. We sequenced 14 human genomes using the three platforms and evaluated single nucleotide variants (SNVs), insertions/deletions (indels), and structural variants (SVs) detection, stratifying by high-complexity, low-complexity, and dark genome regions while assessing effects of multiplexing, depth, and read length. LRS SNV accuracy was slightly lower than that of SRS in high-complexity regions (F-measure: 0.954 vs. 0.967) but showed comparable sensitivity in low-complexity regions. LRS showed robust performance for small (1–5 bp) indels in high-complexity regions (F-measure: 0.869), but SRS agreement decreased significantly in low-complexity regions and for larger indel sizes. Within dark regions, LRS identified more indels than SRS, but showed lower base-level accuracy. LRS identified 2.86 times more SVs than SRS, excelling at detecting large variants (>6 kb), with SV detection improving with sequencing depth. Sequencing depth strongly influenced variant calling performance, whereas multiplexing effects were minimal. Our findings provide valuable insights for optimising LRS applications in genomic research and diagnostics.
Dysregulated DNA methylation in the endothelium is linked to cardiovascular disease development. Ten-eleven translocation 2 (TET2), a DNA demethylase, plays a regulatory role in endothelial function. Loss of endothelial-expressed TET2 correlates with atherosclerosis progression in vivo and alters vasoactive signalling in vitro. Hyperglycaemia acts to downregulate TET2 stability and activity in endothelial cells, but the relevance of this to endothelial dysfunction in diabetes remains unclear. Here, we explore the transcriptional and functional consequences of endothelial-specific TET2 loss in vivo and assess the role of DNA methylation in TET2-dependent transcriptional regulation. Ex vivo aortic responses to acetylcholine and phenylephrine were equivalent between wild-type and endothelial-specific TET2 knockout (TET2KO) mice. RNA sequencing of endothelial-enriched lung cells from TET2KO mice revealed significant dysregulation of interferon signalling. In cultured endothelial cells, qPCR, hydroxymethylated-DNA immunoprecipitation sequencing and nanopore sequencing showed that IFITM1 and ISG15-classical interferon-responsive genes-were negatively regulated by TET2 independently of DNA demethylation. Conversely, the IFNγ-inducible chemokines CXCL9 and CXCL10 were positively regulated by TET2 in a mechanism involving catalytic demethylation, as evidenced by increased 5hmC and decreased 5mC at an enhancer region. Strikingly, approximately 70% of transcriptional changes observed in TET2KO endothelium were mirrored in diabetic mouse endothelium. Pathway analysis highlighted dysregulation of interferon signalling and altered glycosaminoglycan metabolism as the most significant biological consequences. In summary, endothelial TET2 loss leads to transcriptional dysregulation of interferon-regulated genes, partly through altered DNA methylation. This may have relevance to the susceptibility of diabetics to recurrent viral infections and endothelial dysfunction.
Oxford Nanopore Technologies (ONT) long-read sequencing (LRS) has emerged as a promising tool for genomic analysis, but comprehensive comparisons with established platforms across diverse datasets remain limited. We present a multi-platform benchmark using 14 human genomes sequenced with ONT LRS, Illumina short-read sequencing (SRS), and Illumina microarrays. Our study evaluates LRS performance for various genetic variants across genomic contexts, while also examining the impact of experimental factors such as multiplexing, depth, and read length. In high-complexity regions, LRS demonstrated competitive yet slightly lower accuracy than SRS for SNV detection (F-measure: 0.954 vs. 0.968), with performance gaps narrowing in low-complexity regions. For indel detection, LRS showed robust performance for small indels (1-5bp) in high-complexity regions (F-measure: 0.869), but accuracy decreased significantly in low-complexity regions and for larger indels. LRS identified 2.86 times more structural variants than SRS, with superior detection of large-scale variations. Sequencing depth strongly influenced variant calling performance across all variant types, while multiplexing effects were minimal after controlling for depth. Our findings provide valuable insights for optimising ONT LRS applications in genomic research and clinical diagnostics.